The White House. National HIV/AIDS strategy for the United States 2022–2025 [Internet]. Washington, DC; 2021. Available from: https://files.hiv.gov/s3fs-public/NHAS-2022-2025.pdf [Last accessed: Jun11, 2024].
UNAIDS. Overcoming disruption: Transforming the AIDS response - World AIDS Day 2025 report. 2025.
4.
ValliantSN, BurbageSC, PathakS, et al.Pharmacists as accessible health care providers: Quantifying the opportunity. J Manag Care Spec Pharm, 2022; 28(1):85–90; doi: 10.18553/jmcp.2022.28.1.85
5.
Infectious Diseases Society of America. Position of the Infectious Diseases Society of America and the HIV Medicine Association on team-based infectious diseases care and the roles of advanced practice providers and clinical pharmacists. Clinical Infectious Diseases, 2024; doi: 10.1093/cid/ciae265
6.
HavensJP, ScarsiKK, SaylesH, et al.Acceptability and feasibility of a pharmacist-led human immunodeficiency virus pre-exposure prophylaxis program in the Midwestern United States. Open Forum Infect Dis, 2019; 6(10):ofz365; doi: 10.1093/ofid/ofz365
7.
BroekhuisJM, ScarsiKK, SaylesHR, et al.Midwest pharmacists’ familiarity, experience, and willingness to provide pre-exposure prophylaxis (PrEP) for HIV. PLoS One, 2018; 13(11):e0207372; doi: 10.1371/journal.pone.0207372
8.
Panel on Antiretroviral Guidelines for Adults N. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV how to cite the adult and adolescent antiretroviral guidelines: Panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services [Internet]. Available from: https://clinicalinfo.hiv.gov/
9.
SunagawaSW, FloydCC, BaresSH, et al.Long-acting Cabotegravir/Rilpivirine for treatment of HIV during pregnancy: A case series. Open Forum Infect Dis, 2025; 12(11):ofaf649; doi: 10.1093/ofid/ofaf649
10.
SunagawaSW, BaresSH, ScarsiKK, et al.Sustained HIV viral suppression 18 months after the last dose of long-acting Cabotegravir/Rilpivirine: A case report. Open Forum Infect Dis, 2025; 12(7):ofaf399; doi: 10.1093/OFID/OFAF399
11.
LeeSS, HavensJP, SaylesHR, et al.A pharmacist-led medication switch protocol in an academic HIV clinic: Patient knowledge and satisfaction. BMC Infect Dis, 2018; 18(1):310; doi: 10.1186/s12879-018-3226-2
12.
SunagawaSW, CodlingG, LydenE, et al.Utilization of doxycycline postexposure prophylaxis at a Midwestern United States HIV/PrEP Clinic. Open Forum Infect Dis, 2025; 12(2):ofaf062; doi: 10.1093/ofid/ofaf062
